Support line (toll-free) (844) 835-4325 | Events help (608) 828-8852 | Community

Free To Breathe - A Partnership For Lung Cancer Survival

participant Login

News

Improving Radiation Therapy for NSCLC

  • April 11 2014

    Share |
    Improving Radiation Therapy for NSCLC

    Radiation therapy (also sometimes referred to as radiotherapy, x-ray therapy, or irradiation) uses x-rays or other high-energy beams to damage cancer cells and stop them from growing or multiplying. Because radiation also affects normal cells, this therapy is aimed directly at the cancer tumor. Stereotactic body radiotherapy (SBRT) is a very effective radiation therapy, but it can cause side effects when the radiation hits healthy organs on its way to or from the tumor.

    This clinical trial compares the effectiveness and side effects of SBRT and a similar radiation therapy technique, called stereotactic body proton radiotherapy (SBPT). SBPT uses protons, a different kind of energy beam than SBRT; protons are thought to minimize damage to other parts of the body.

    Eligibility
    Non-small cell lung cancer (NSCLC) patients with unresectable stage I lung cancer are eligible for this clinical trial. Certain stage II or recurrent NSCLC patients may also participate, depending on other eligibility requirements.

    Learn more about this clinical trial >

    0 comments

Leave a comment

Comment Guidelines

Basic HTML formatting permitted -
<ul>, <li>, <strong>, <em>, <a href>, <blockquote>, <code>

©2017 Free To Breathe | Lung Cancer Research Foundation | Federal Tax ID #14-1935776 | LCRF is a 501(c)(3) public charity.